-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Sector Perform on Regeneron Pharmaceuticals, Raises Price Target to $737

Benzinga·07/31/2026 19:39:48
Listen to the news
RBC Capital analyst Brian Abrahams maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Sector Perform and raises the price target from $696 to $737.